Curaleaf Holdings, Inc.

CURA.TO·Toronto·Healthcare
Compare
13.40−0.83 (−5.83%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · CAD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close14.23
Open14.01
Day range12.9014.28
52-week range7.7720.93
Off day high−6.16%
Off 52-week high−35.96%
Volume515.85K
Avg. volume (3M)359.56K
Market cap3.55B
EPS (TTM)-0.0700
Forward P/E-17.01
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.76
Shares outstanding233.54M
Short interest—
Earnings dateNov 3, 2026
Analyst target18.08
Profit margin−2.63%

Against its peers

Compare in full ›
CURA.TO TRLV CRON 6CQ.F ACB CGC
Market cap 3.55B 2.23B 1.29B 186.60M 331.74M 337.74M
P/E (TTM) — — 18.5 — — —
Forward P/E -17.0 20.6 -87.8 — -47.6 -6.2
Price/book 3.2 2.9 1.2 0.6 0.9 0.6
Dividend yield — — — — — —
1-year change +18.29% +70.46% +37.96% −36.54% +15.70% −37.98%
Today −5.83% +0.52% +3.85% −5.97% +1.55% +6.37%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Latest news

All CURA.TO news ›
Securities.io·

Curaleaf Keeps Aurora Bid Open After Rival Organigram Deal

Curaleaf Holdings announced on November 3, 2026 that its enhanced takeover offer for Aurora Cannabis (ACB ) remains outstanding after Aurora agreed to a competing acquisition by Organigram Global (OGI ). The rival transaction offers C$7.80…

CBC··2 outletsPositive

Organigram signs friendly deal to buy Edmonton-based Aurora Cannabis after hostile Curaleaf offer

Organigram Global Inc. has signed a deal to buy Aurora Cannabis Inc. in an agreement that values the company at $561 million, after a hostile offer from Curaleaf was rebuffed earlier this year. Organigram CEO James Yamanaka says the…

More from 1 other outlet

From the 4Search news index, newest first.

In the news

108mentions in 30 days
103with it in the headline
Mixedsentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 108 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance